For life sciences companies struggling to find crucial insights into rare diseases, the internet offers a trove of public data to tap into to learn more. As many as 7,000 rare conditions together affect an estimated 25 to 30 million Americans in total. While breakthroughs for novel therapies offer a promising way to shift the macabre trajectory of some life-threatening rare diseases, many more await remedies. The small, often dispersed populations make studying them, developing treatments, and recruiting for clinical trials extremely difficult.
By Youbean Oak and Paige Cooper
This byline originally appeared in Cell & Gene
Guidehouse is a global advisory, technology, and managed services firm delivering value to commercial businesses and federal, state, and local governments. Serving industries focused on communities, energy, and infrastructure, healthcare, financial services, and defense and national security, we position clients for AI-led innovation, efficiency, and resilience.